Klaviyo R&D Spending Growth & History (KVYO)
Klaviyo's r&d spending was $291.2M for fiscal 2025.
View full Klaviyo company overviewKlaviyo annual r&d spending history
| Fiscal year | Period ended | R&D spending | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $291.2M | $52.8M | +22.12% |
| 2024 | 2024-12-31 | $238.5M | −$23.7M | −9.05% |
| 2023 | 2023-12-31 | $262.2M | $158.1M | +151.91% |
| 2022 | 2022-12-31 | $104.1M | $38.5M | +58.66% |
| 2021 | 2021-12-31 | $65.6M | — | — |
Klaviyo quarterly r&d spending
| Fiscal quarter | Period ended | R&D spending | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $91.9M | $19.5M | +26.87% |
| Q1 2026 | 2026-03-31 | $80.0M | $10.7M | +15.40% |
| Q4 2025 | 2025-12-31 | $76.7M | $5.9M | +8.29% |
| Q3 2025 | 2025-09-30 | $72.7M | $16.9M | +30.30% |
| Q2 2025 | 2025-06-30 | $72.5M | $16.7M | +30.01% |
| Q1 2025 | 2025-03-31 | $69.3M | $13.3M | +23.62% |
| Q4 2024 | 2024-12-31 | $70.9M | $18.2M | +34.62% |
| Q3 2024 | 2024-09-30 | $55.8M | −$85.7M | −60.57% |
| Q2 2024 | 2024-06-30 | $55.7M | $22.7M | +68.61% |
| Q1 2024 | 2024-03-31 | $56.1M | $21.1M | +60.13% |
| Q4 2023 | 2023-12-31 | $52.6M | — | — |
| Q3 2023 | 2023-09-30 | $141.5M | $111.4M | +370.11% |
| Q2 2023 | 2023-06-30 | $33.1M | — | — |
| Q1 2023 | 2023-03-31 | $35.0M | — | — |
| Q3 2022 | 2022-09-30 | $30.1M | — | — |
Klaviyo r&d spending trends
Between the periods ended 2021-12-31 and 2025-12-31, Klaviyo's r&d spending increased from $65.6M to $291.2M, a change of $225.6M. The latest reported quarter, Q2 2026, shows $91.9M.
What research and development spending means
Research and development (R&D) spending covers the costs of creating and improving products, services, software, technologies, and processes. Higher R&D spending may support future innovation, but the amount alone does not show whether those investments will generate returns.
SEC-reported R&D expense
TickerStat standardizes research and development expense reported in company SEC filings, including the software-specific US-GAAP R&D concept when it is the filer’s primary R&D expense line. It is historical company-reported spending, not an estimate or forecast. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Klaviyo source filings ↗